Health Catalyst [HCAT] vs Veeva Systems [VEEV] Detailed Stock Comparison
Health Catalyst
NASDAQ
Loading...
Veeva Systems
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Health Catalyst wins in 6 metrics, Veeva Systems wins in 12 metrics, with 0 ties. Veeva Systems appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Health Catalyst | Veeva Systems | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -2.96 | 55.28 | Health Catalyst |
| Price-to-Book Ratio | 0.69 | 6.63 | Health Catalyst |
| Debt-to-Equity Ratio | 49.72 | 1.29 | Veeva Systems |
| PEG Ratio | -0.02 | 1.38 | Health Catalyst |
| EV/EBITDA | -17.54 | 43.34 | Health Catalyst |
| Profit Margin (TTM) | -31.67% | 27.29% | Veeva Systems |
| Operating Margin (TTM) | -14.45% | 28.71% | Veeva Systems |
| EBITDA Margin (TTM) | N/A | 28.71% | N/A |
| Return on Equity | -28.42% | 13.70% | Veeva Systems |
| Return on Assets (TTM) | -4.99% | 7.24% | Veeva Systems |
| Free Cash Flow (TTM) | $-1.84M | $1.09B | Veeva Systems |
| 1-Year Return | -52.85% | 24.38% | Veeva Systems |
| Price-to-Sales Ratio (TTM) | 0.75 | 14.82 | Health Catalyst |
| Enterprise Value | $314.02M | $37.69B | Veeva Systems |
| EV/Revenue Ratio | 0.99 | 12.70 | Health Catalyst |
| Gross Profit Margin (TTM) | 47.37% | 77.10% | Veeva Systems |
| Revenue per Share (TTM) | $5 | $18 | Veeva Systems |
| Earnings per Share (Diluted) | $-1.51 | $4.87 | Veeva Systems |
| Beta (Stock Volatility) | 1.46 | 0.96 | Veeva Systems |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Health Catalyst vs Veeva Systems Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Health Catalyst | -7.12% | 3.35% | -13.52% | -9.36% | -27.41% | -53.81% |
| Veeva Systems | -1.15% | -7.45% | -6.28% | -3.53% | 20.10% | 27.84% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Health Catalyst | -52.85% | -70.47% | -89.45% | -91.15% | -91.15% | -91.15% |
| Veeva Systems | 24.38% | 58.38% | -0.14% | 987.24% | 506.44% | 506.44% |
Performance & Financial Health Analysis: Health Catalyst vs Veeva Systems
| Metric | HCAT | VEEV |
|---|---|---|
| Market Information | ||
| Market Cap | $322.97M | $35.55B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 975,000 | 1,699,050 |
| 90 Day Avg. Volume | 898,457 | 1,339,037 |
| Last Close | $3.39 | $269.20 |
| 52 Week Range | $2.52 - $9.24 | $200.30 - $296.72 |
| % from 52W High | -63.31% | -9.27% |
| All-Time High | $59.50 (Jun 07, 2021) | $343.96 (Aug 02, 2021) |
| % from All-Time High | -94.30% | -21.74% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.17% |
| Quarterly Earnings Growth | N/A | 0.17% |
| Financial Health | ||
| Profit Margin (TTM) | -0.32% | 0.27% |
| Operating Margin (TTM) | -0.14% | 0.29% |
| Return on Equity (TTM) | -0.28% | 0.14% |
| Debt to Equity (MRQ) | 49.72 | 1.29 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $4.95 | $40.60 |
| Cash per Share (MRQ) | $1.38 | $39.17 |
| Operating Cash Flow (TTM) | $-6,036,000 | $1.35B |
| Levered Free Cash Flow (TTM) | $8.72M | $1.10B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Health Catalyst vs Veeva Systems
| Metric | HCAT | VEEV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -2.96 | 55.28 |
| Forward P/E | 8.07 | 39.82 |
| PEG Ratio | -0.02 | 1.38 |
| Price to Sales (TTM) | 0.75 | 14.82 |
| Price to Book (MRQ) | 0.69 | 6.63 |
| Market Capitalization | ||
| Market Capitalization | $322.97M | $35.55B |
| Enterprise Value | $314.02M | $37.69B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.99 | 12.70 |
| Enterprise to EBITDA | -17.54 | 43.34 |
| Risk & Other Metrics | ||
| Beta | 1.46 | 0.96 |
| Book Value per Share (MRQ) | $4.95 | $40.60 |
Financial Statements Comparison: Health Catalyst vs Veeva Systems
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HCAT | VEEV |
|---|---|---|
| Revenue/Sales | $79.41M | $759.04M |
| Cost of Goods Sold | $43.18M | $173.82M |
| Gross Profit | $36.24M | $585.22M |
| Research & Development | $15.19M | $184.03M |
| Operating Income (EBIT) | $-20.17M | $233.73M |
| EBITDA | $-3.89M | $243.55M |
| Pre-Tax Income | $-23.53M | $298.82M |
| Income Tax | $215,000 | $70.63M |
| Net Income (Profit) | $-23.74M | $228.19M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HCAT | VEEV |
|---|---|---|
| Cash & Equivalents | $341.97M | $1.96B |
| Total Current Assets | $422.72M | $6.71B |
| Total Current Liabilities | $339.56M | $1.46B |
| Long-Term Debt | $167.04M | $66.57M |
| Total Shareholders Equity | $376.81M | $6.21B |
| Retained Earnings | $-1.21B | $3.68B |
| Property, Plant & Equipment | $11.88M | $122.23M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HCAT | VEEV |
|---|---|---|
| Operating Cash Flow | $-380,000 | $810.54M |
| Capital Expenditures | $-663,000 | N/A |
| Free Cash Flow | $-5.05M | $877.16M |
| Debt Repayment | $-407,000 | N/A |
| Common Stock Repurchase | $-5.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | HCAT | VEEV |
|---|---|---|
| Shares Short | 4.90M | 4.69M |
| Short Ratio | 6.23 | 4.07 |
| Short % of Float | 0.08% | 0.03% |
| Average Daily Volume (10 Day) | 975,000 | 1,699,050 |
| Average Daily Volume (90 Day) | 898,457 | 1,339,037 |
| Shares Outstanding | 64.04M | 162.58M |
| Float Shares | 64.26M | 150.00M |
| % Held by Insiders | 0.03% | 0.09% |
| % Held by Institutions | 0.80% | 0.90% |
Dividend Analysis & Yield Comparison: Health Catalyst vs Veeva Systems
| Metric | HCAT | VEEV |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |